---
title: "KMYY: Plans to sign a settlement agreement with related party Guangzhou Pharmaceutical Group to resolve historical debt issues for 43.5 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248915548.md"
description: "KMYY announced that its wholly-owned subsidiary Chengdu KMYY Pharmaceutical Co., Ltd. intends to sign a settlement agreement with Guangzhou Pharmaceutical Group Co., Ltd. to settle the aforementioned debt with 43.5 million yuan and related handling fees. After the payment is completed, the Guangzhou Pharmaceutical Group will assist Chengdu KMYY in handling the execution unsealing and case closure procedures. This transaction constitutes a related party transaction but does not constitute a major asset reorganization"
datetime: "2025-07-17T07:37:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248915548.md)
  - [en](https://longbridge.com/en/news/248915548.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248915548.md)
---

# KMYY: Plans to sign a settlement agreement with related party Guangzhou Pharmaceutical Group to resolve historical debt issues for 43.5 million yuan

KMYY announced that its wholly-owned subsidiary Chengdu KMYY Pharmaceutical Co., Ltd. intends to sign a settlement agreement with Guangzhou Pharmaceutical Group Co., Ltd. to settle the aforementioned debt with 43.5 million yuan and related handling fees. After the payment is completed, Guangzhou Pharmaceutical Group will assist Chengdu KMYY in handling the execution unsealing and case closure procedures. This transaction constitutes a related party transaction but does not constitute a major asset restructuring

### Related Stocks

- [600518.CN](https://longbridge.com/en/quote/600518.CN.md)

## Related News & Research

- [Dunkin' To Give Away 1 Mln Free Coffees For A Day](https://longbridge.com/en/news/286964019.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Sparebanken Øst Buys Back Equity Certificates for Employee Savings Scheme](https://longbridge.com/en/news/286813438.md)
- [BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026](https://longbridge.com/en/news/287043048.md)
- [Apnimed's sleep apnea pill meets main goal in late-stage study](https://longbridge.com/en/news/286785038.md)